Bylenta MLN 10 mg/25 mg/40 mg Tablet 15's

Bylenta MLN 10 mg/25 mg/40 mg Tablet belongs to the group of anti-hypertensive medicines used to treat high blood pressure (hypertension). Bylenta MLN 10 mg/25 mg/40 mg Tablet helps lower blood pressure, thereby reduces the chances of heart problems such as heart attack and stroke. High blood pressure is a condition in which the blood exerts increased pressure on the walls of blood vessels. Symptoms include headache, dizziness, nosebleeds, changes in vision, chest pain, weakness and dyspnea (shortness of breath). However, most of the time, the signs and symptoms of hypertension are none.
 
Bylenta MLN 10 mg/25 mg/40 mg Tablet is a combination of three drugs, namely: Cilnidipine, Telmisartan, and Metoprolol. Cilnidipine acts on the calcium channels of the blood vessels and suppresses the contraction of blood vessels, thereby helps blood flow smoothly. Telmisartan works by blocking the angiotensin II receptor, thereby relaxes the blood vessels and lowers the blood pressure. Metoprolol slows down the heart rate and makes it easier for the heart to pump blood throughout the body. Together, Bylenta MLN 10 mg/25 mg/40 mg Tablet helps treat hypertension.
 
You are advised to take Bylenta MLN 10 mg/25 mg/40 mg Tablet for as long as your doctor has prescribed it for you, depending on your medical condition. In some cases, you may experience certain common side-effects such as headache, nausea, dizziness, weakness, decreased blood pressure and slow heart rate. Most of these side effects do not require medical attention and will resolve gradually over time. However, you are advised to talk to your doctor if you experience these side effects persistently.
 
Try not to stop taking it on your own, as it may cause a sudden increase the blood pressure. Consult your doctor if you are pregnant or breastfeeding. Bylenta MLN 10 mg/25 mg/40 mg Tablet is not recommended for children as efficacy and safety have not been established. Bylenta MLN 10 mg/25 mg/40 mg Tablet may cause dizziness, so drive with caution. Avoid consuming alcohol as it might cause increased dizziness. Inform your doctor about all the medicines you are taking and your health condition to rule out any unpleasant side effects/interactions.

Bylenta MLN 10 mg/25 mg/40 mg Tablet is a combination of three drugs, namely: Cilnidipine, Telmisartan, and Metoprolol. Bylenta MLN 10 mg/25 mg/40 mg Tablet is used to treat hypertension. Cilnidipine is a calcium channel blocker that acts on the calcium channels of the blood vessels and suppresses the contraction of blood vessels, thereby helps blood flow smoothly. Telmisartan is an angiotensin receptor blocker that works by blocking the angiotensin II receptor, thereby relaxes the blood vessels and lowers the blood pressure. Metoprolol is a beta-blocker that slows down the heart rate and makes it easier for the heart to pump blood throughout the body. Together, Bylenta MLN 10 mg/25 mg/40 mg Tablet helps treat hypertension. Bylenta MLN 10 mg/25 mg/40 mg Tablet helps lower blood pressure, thereby reduces the chances of heart problems such as heart attack and stroke.

• Headache
• Nausea
• Weakness
• Slow heart rate (bradycardia)
• Dizziness 

Do not take Bylenta MLN 10 mg/25 mg/40 mg Tablet if you are allergic to any of its contents. Inform your doctor if you have diabetes, circulation problems, asthma, thyroid disorder, adrenal gland tumour, heart, kidney, or liver problems; if you are on a low-salt diet or if you are taking potassium supplements. Consult your doctor if you are pregnant or breastfeeding. Bylenta MLN 10 mg/25 mg/40 mg Tablet is not recommended for children as efficacy and safety have not been established. Bylenta MLN 10 mg/25 mg/40 mg Tablet may cause dizziness, so drive with caution. Avoid consuming alcohol as it might cause increased dizziness. Rise slowly from lying/sitting position as Bylenta MLN 10 mg/25 mg/40 mg Tablet may cause dizziness (orthostatic hypotension).

Drug-Drug Interactions: Bylenta MLN 10 mg/25 mg/40 mg Tablet may interact with painkiller (aspirin), anti-convulsant (pregabalin, phenytoin), anti-depressant (duloxetine), anti-diabetic (insulin glargine), diuretic (furosemide), hormone (levothyroxine), antibiotics (erythromycin, rifampicin), anti-arrhythmic agent (quinidine), cytokines (aldesleukin).

Drug-Food Interactions: No interactions found/established.

Drug-Disease Interactions: Inform your doctor if you have diabetes, renal dysfunction (kidney disease), pulmonary disease, alcoholism, congestive heart failure (heart disease), hypotension (low blood pressure) or liver disease.

• ASPIRIN
• PREGABALIN
• PHENYTOIN
• DULOXETINE
• INSULIN GLARGINE
• FUROSEMIDE
• LEVOTHYROXINE
• ERYTHROMYCIN
• RIFAMPICIN
• QUINIDINE
• ALDESLEUKIN

• Consume low salt and low-fat diet. 

• Regular exercise is also recommended to complement treatment with Bylenta MLN 10 mg/25 mg/40 mg Tablet .

• Eat a diet rich in whole grains, vegetables, and fruits.

• Avoid smoking and alcohol consumption.

• Maintain a healthy weight with proper diet and exercise.

• Managing stress with meditation, yoga, massage would also help in treating high blood pressure.

• Avoid consuming food rich in potassium, such as banana, broccoli, almonds, avocado, and potassium supplements.

• Regular monitoring of blood pressure levels, kidney function and electrolyte levels while taking Bylenta MLN 10 mg/25 mg/40 mg Tablet is advised.

High blood pressure (hypertension): It is a condition in which the blood exerts increased pressure on the walls of blood vessels leading to hypertension. This condition can lead to hardened arteries (blood vessels), decreasing the blood and oxygen flow to the heart. Raised blood pressure can cause chest pain (angina) and heart attack (when the blood supply to the heart is blocked). Additionally, high blood pressure also causes brain damage (stroke) and kidney failure. Symptoms of high blood pressure include headache, dizziness, nose bleed, changes in vision, chest pain, weakness and dyspnoea (shortness of breath). However, most of the time, the signs and symptoms of hypertension are none.